Inpefa Interactions
There are 363 drugs known to interact with Inpefa (sotagliflozin), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 1 is major, 361 are moderate, and 1 is minor.
- View all 363 medications that may interact with Inpefa
- View Inpefa alcohol/food interactions (1)
- View Inpefa disease interactions (4)
Most frequently checked interactions
View interaction reports for Inpefa (sotagliflozin) and the medicines listed below.
- acetaminophen
- acetaminophen / oxycodone
- Advil Dual Action (acetaminophen / ibuprofen)
- albuterol
- Allegra Allergy (fexofenadine)
- allopurinol
- amlodipine
- amoxicillin
- amoxicillin / clavulanate
- Anoro Ellipta (umeclidinium / vilanterol)
- aspirin
- atorvastatin
- carvedilol
- clonazepam
- cyclobenzaprine
- DayQuil / NyQuil Severe Cold and Flu (acetaminophen / dextromethorphan / doxylamine / guaifenesin / phenylephrine)
- Entresto (sacubitril / valsartan)
- furosemide
- gabapentin
- lisinopril
- losartan
- melatonin
- Metoprolol Succinate ER (metoprolol)
- spironolactone
- trazodone
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- valsartan
- Vitamin C (ascorbic acid)
- Zyrtec (cetirizine)
- Zyrtec-D (cetirizine / pseudoephedrine)
Inpefa alcohol/food interactions
There is 1 alcohol/food interaction with Inpefa (sotagliflozin).
Inpefa disease interactions
There are 4 disease interactions with Inpefa (sotagliflozin) which include:
More about Inpefa (sotagliflozin)
- Inpefa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous cardiovascular agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.